FDA Updates in Urology: January 2025
New Horizons in Urology: A Glimpse into Future Trends Radical Enhancements in Prostate Cancer Treatment The landscape of prostate cancer treatment is rapidly evolving. With the FDA’s fast track designation of 64Cu-SAR-bisPSMA for advanced imaging, real-life case studies demonstrate the agent’s power in altering treatment plans for up to 48% of patients through improved lesion … Read more